Yeast prions and human prion-like proteins: Sequence features and prediction methods

Cellular and Molecular Life Sciences

Volumn 71, Issue 11, 2014, Pages 2047-2063

  Cascarina, Sean M ^a   Ross, Eric D ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Amyloid; Amyotrophic lateral sclerosis; Prion; Prion like domains; Yeast

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; HEAT SHOCK PROTEIN 104; PRION PROTEIN; RNA BINDING PROTEIN; TAU PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; DISEASE ASSOCIATION; HUMAN; HYDROPHOBICITY; NONHUMAN; POINT MUTATION; PREDICTION; PRION; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REVIEW; SACCHAROMYCES CEREVISIAE; YEAST;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; GENE EXPRESSION; HUMANS; MOLECULAR SEQUENCE DATA; PRION DISEASES; PRIONS; PROTEIN DENATURATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84901676719     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1543-6     Document Type: Review

References (117)

1. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333-366
2. Alberti S, Halfmann R, King O, Kapila A, Lindquist S (2009) A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137(1):146-158
3. Derkatch IL, Bradley ME, Hong JY, Liebman SW (2001) Prions affect the appearance of other prions: the story of [PIN(+)]. Cell 106(2):171-182
4. Du Z, Park KW, Yu H, Fan Q, Li L (2008) Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. Nat Genet 40(4):460-465
5. Patel BK, Gavin-Smyth J, Liebman SW (2009) The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion. Nat Cell Biol 11(3):344-349
6. Rogoza T, Goginashvili A, Rodionova S, Ivanov M, Viktorovskaya O, Rubel A, Volkov K, Mironova L (2010) Non-Mendelian determinant [ISP+] in yeast is a nuclear-residing prion form of the global transcriptional regulator Sfp1. Proc Natl Acad Sci USA 107(23):10573-10577
7. Sondheimer N, Lindquist S (2000) Rnq1: an epigenetic modifier of protein function in yeast. Mol Cell 5(1):163-172
8. Suzuki G, Shimazu N, Tanaka M (2012) A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress. Science 336(6079):355-359. doi: 10.1126/science.1219491
9. Wickner RB (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264(5158):566-569
10. Halfmann R, Wright J, Alberti S, Lindquist S, Rexach M (2012) Prion formation by a yeast GLFG nucleoporin. Prion 6(4):391-399
11. Fowler DM, Koulov AV, Balch WE, Kelly JW (2007) Functional amyloid-from bacteria to humans. Trends Biochem Sci 32(5):217-224
12. Eaglestone SS, Cox BS, Tuite MF (1999) Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J 18(7):1974-1981
13. True HL, Lindquist SL (2000) A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407(6803):477-483
14. Tyedmers J, Madariaga ML, Lindquist S (2008) Prion switching in response to environmental stress. PLoS Biol 6(11):e294
15. Bateman DA, Wickner RB (2012) [PSI+] Prion transmission barriers protect Saccharomyces cerevisiae from infection: intraspecies 'species barriers'. Genetics 190(2):569-579. doi: 10.1534/genetics.111.136655
16. Kelly AC, Wickner RB (2013) Saccharomyces cerevisiae: a sexy yeast with a prion problem. Prion 7(3):215-220. doi: 10.4161/pri.24845
17. Nakayashiki T, Kurtzman CP, Edskes HK, Wickner RB (2005) Yeast prions [URE3] and [PSI+] are diseases. Proc Natl Acad Sci USA 102(30):10575-10580
18. Wickner RB, Edskes HK, Bateman D, Kelly AC, Gorkovskiy A (2011) The yeast prions [PSI+] and [URE3] are molecular degenerative diseases. Prion 5(4):258-262. doi: 10.4161/pri.17748
19. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363-13383
20. Couthouis J, Hart MP, Shorter J, Dejesus-Hernandez M, Erion R, Oristano R, Liu AX, Ramos D, Jethava N, Hosangadi D, Epstein J, Chiang A, Diaz Z, Nakaya T, Ibrahim F, Kim HJ, Solski JA, Williams KL, Mojsilovic-Petrovic J, Ingre C, Boylan K, Graff-Radford NR, Dickson DW, Clay-Falcone D, Elman L, McCluskey L, Greene R, Kalb RG, Lee VM, Trojanowski JQ, Ludolph A, Robberecht W, Andersen PM, Nicholson GA, Blair IP, King OD, Bonini NM, Van Deerlin V, Rademakers R, Mourelatos Z, Gitler AD (2011) A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci USA 108:20881-20890. doi: 10.1073/pnas.1109434108
21. King OD, Gitler AD, Shorter J (2012) The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 1462:61-80. doi: 10.1016/j.brainres.2012.01.016
22. Harrison PM, Gerstein M (2003) A method to assess compositional bias in biological sequences and its application to prion-like glutamine/asparagine-rich domains in eukaryotic proteomes. Genome Biol 4(6):R40
23. Michelitsch MD, Weissman JS (2000) A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc Natl Acad Sci USA 97(22):11910-11915
24. Cox BS (1965) PSI, a cytoplasmic suppressor of super-suppressor in yeast. Heredity 26:211-232
25. Lacroute F (1971) Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J Bacteriol 106(2):519-522
26. Doel SM, McCready SJ, Nierras CR, Cox BS (1994) The dominant PNM2- mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137(3):659-670
27. Kushnirov VV, Ter-Avanesyan MD, Telckov MV, Surguchov AP, Smirnov VN, Inge-Vechtomov SG (1988) Nucleotide sequence of the SUP2 (SUP35) gene of Saccharomyces cerevisiae. Gene 66(1):45-54
28. Masison DC, Wickner RB (1995) Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270(5233):93-95
29. Ter-Avanesyan MD, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN (1994) The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 137(3):671-676
30. Ter-Avanesyan MD, Kushnirov VV, Dagkesamanskaya AR, Didichenko SA, Chernoff YO, Inge-Vechtomov SG, Smirnov VN (1993) Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol Microbiol 7(5):683-692
31. Liu JJ, Sondheimer N, Lindquist SL (2002) Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+]. Proc Natl Acad Sci USA 99(Suppl 4):16446-16453
32. Baxa U, Speransky V, Steven AC, Wickner RB (2002) Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein. Proc Natl Acad Sci USA 99(8):5253-5260
33. Li L, Lindquist S (2000) Creating a protein-based element of inheritance. Science 287(5453):661-664
34. Pierce MM, Baxa U, Steven AC, Bax A, Wickner RB (2005) Is the prion domain of soluble Ure2p unstructured? Biochemistry 44(1):321-328
35. Serio TR, Cashikar AG, Kowal AS, Sawicki GJ, Moslehi JJ, Serpell L, Arnsdorf MF, Lindquist SL (2000) Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289(5483):1317-1321
36. Ross ED, Baxa U, Wickner RB (2004) Scrambled prion domains form prions and amyloid. Mol Cell Biol 24(16):7206-7213
37. Ross ED, Edskes HK, Terry MJ, Wickner RB (2005) Primary sequence independence for prion formation. Proc Natl Acad Sci USA 102(36):12825-12830
38. Du Z (2011) The complexity and implications of yeast prion domains. Prion 5(4):311-316. doi: 10.4161/pri.18304
39. Maclea KS, Ross ED (2011) Strategies for identifying new prions in yeast. Prion 5(4):263-268
40. DePace AH, Santoso A, Hillner P, Weissman JS (1998) A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93(7):1241-1252
41. Santoso A, Chien P, Osherovich LZ, Weissman JS (2000) Molecular basis of a yeast prion species barrier. Cell 100(2):277-288
42. Chen B, Bruce KL, Newnam GP, Gyoneva S, Romanyuk AV, Chernoff YO (2010) Genetic and epigenetic control of the efficiency and fidelity of cross-species prion transmission. Mol Microbiol 76(6):1483-1499
43. Osherovich LZ, Cox BS, Tuite MF, Weissman JS (2004) Dissection and design of yeast prions. PLoS Biol 2(4):E86
44. Parham SN, Resende CG, Tuite MF (2001) Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions. EMBO J 20(9):2111-2119
45. Shkundina IS, Kushnirov VV, Tuite MF, Ter-Avanesyan MD (2006) The role of the N-terminal oligopeptide repeats of the yeast sup35 prion protein in propagation and transmission of prion variants. Genetics 172(2):827-835
46. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, Eisenberg D (2005) Structure of the cross-beta spine of amyloid-like fibrils. Nature 435(7043):773-778
47. Fei L, Perrett S (2009) Disulfide bond formation significantly accelerates the assembly of Ure2p fibrils because of the proximity of a potential amyloid stretch. J Biol Chem 284(17):11134-11141. doi: 10.1074/jbc.M809673200
48. Tessier PM, Lindquist S (2007) Prion recognition elements govern nucleation, strain specificity and species barriers. Nature 447(7144):556-561
49. Crow ET, Du Z, Li L (2011) A small, glutamine-free domain propagates the [SWI(+)] prion in budding yeast. Mol Cell Biol 31(16):3436-3444. doi: 10.1128/MCB.05338-11
50. Vitrenko YA, Pavon ME, Stone SI, Liebman SW (2007) Propagation of the [PIN+] prion by fragments of Rnq1 fused to GFP. Curr Genet 51(5):309-319
51. Kadnar ML, Articov G, Derkatch IL (2010) Distinct type of transmission barrier revealed by study of multiple prion determinants of Rnq1. PLoS 6(1):e1000824
52. Osherovich LZ, Weissman JS (2001) Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell 106(2):183-194
53. Kabani M, Cosnier B, Bousset L, Rousset JP, Melki R, Fabret C (2011) A mutation within the C-terminal domain of Sup35p that affects [PSI(+)] prion propagation. Mol Microbiol 81(3):640-658
54. Kochneva-Pervukhova NV, Poznyakovski AI, Smirnov VN, Ter-Avanesyan MD (1998) C-terminal truncation of the Sup35 protein increases the frequency of de novo generation of a prion-based [PSI+] determinant in Saccharomyces cerevisiae. Curr Genet 34(2):146-151
55. Helsen CW, Glover JR (2012) Insight into molecular basis of curing of [PSI+] prion by overexpression of 104-kDa heat shock protein (Hsp104). J Biol Chem 287(1):542-556. doi: 10.1074/jbc.M111.302869
56. Shewmaker F, Wickner RB, Tycko R (2006) Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure. Proc Natl Acad Sci USA 103(52):19754-19759
57. Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD (1996) Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 15(12):3127-3134
58. Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW (1995) Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268(5212):880-884
59. Glover JR, Lindquist S (1998) Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94(1):73-82
60. Schirmer EC, Lindquist S (1997) Interactions of the chaperone Hsp104 with yeast Sup35 and mammalian PrP. Proc Natl Acad Sci USA 94(25):13932-13937
61. Shorter J, Lindquist S (2008) Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions. EMBO J 27(20):2712-2724
62. Grimminger-Marquardt V, Lashuel HA (2010) Structure and function of the molecular chaperone Hsp104 from yeast. Biopolymers 93(3):252-276. doi: 10.1002/bip.21301
63. Reidy M, Masison DC (2011) Modulation and elimination of yeast prions by protein chaperones and co-chaperones. Prion 5(4):245-249. doi: 10.4161/pri.17749
64. Moriyama H, Edskes HK, Wickner RB (2000) [URE3] prion propagation in Saccharomyces cerevisiae: requirement for chaperone Hsp104 and curing by overexpressed chaperone Ydj1p. Mol Cell Biol 20(23):8916-8922
65. Volkov KV, Aksenova AY, Soom MJ, Osipov KV, Svitin AV, Kurischko C, Shkundina IS, Ter-Avanesyan MD, Inge-Vechtomov SG, Mironova LN (2002) Novel non-Mendelian determinant involved in the control of translation accuracy in Saccharomyces cerevisiae. Genetics 160(1):25-36
66. Lum R, Tkach JM, Vierling E, Glover JR (2004) Evidence for an unfolding/threading mechanism for protein disaggregation by Saccharomyces cerevisiae Hsp104. J Biol Chem 279(28):29139-29146. doi: 10.1074/jbc.M403777200
67. DeSantis ME, Shorter J (2012) Hsp104 drives "protein-only" positive selection of Sup35 prion strains encoding strong [PSI(+)]. Chem Biol 19(11):1400-1410. doi: 10.1016/j.chembiol.2012.09.013
68. Helsen CW, Glover JR (2012) A new perspective on Hsp104-mediated propagation and curing of the yeast prion [PSI (+)]. Prion 6(3):234-239. doi: 10.4161/pri.19913
69. Toombs JA, Liss NM, Cobble KR, Ben-Musa Z, Ross ED (2011) [PSI+] maintenance is dependent on the composition, not primary sequence, of the oligopeptide repeat domain. PLoS ONE 6(7):e21953
70. Bryan AW Jr, Menke M, Cowen LJ, Lindquist SL, Berger B (2009) BETASCAN: probable beta-amyloids identified by pairwise probabilistic analysis. PLoS Comput Biol 5(3):e1000333
71. Bryan AW Jr, O'Donnell CW, Menke M, Cowen LJ, Lindquist S, Berger B (2011) STITCHER: dynamic assembly of likely amyloid and prion beta-structures from secondary structure predictions. Proteins. doi: 10.1002/prot.23203
72. Tartaglia GG, Pawar AP, Campioni S, Dobson CM, Chiti F, Vendruscolo M (2008) Prediction of aggregation-prone regions in structured proteins. J Mol Biol 380(2):425-436
73. Goldschmidt L, Teng PK, Riek R, Eisenberg D (2010) Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Natl Acad Sci USA 107(8):3487-3492
74. Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 22(10):1302-1306
75. Zibaee S, Makin OS, Goedert M, Serpell LC (2007) A simple algorithm locates beta-strands in the amyloid fibril core of alpha-synuclein, Abeta, and tau using the amino acid sequence alone. Protein Sci 16(5):906-918
76. Trovato A, Seno F, Tosatto SC (2007) The PASTA server for protein aggregation prediction. Protein Eng Des Sel 20(10):521-523
77. Maurer-Stroh S, Debulpaep M, Kuemmerer N, Lopez de la Paz M, Martins IC, Reumers J, Morris KL, Copland A, Serpell L, Serrano L, Schymkowitz JW, Rousseau F (2010) Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat Methods 7(3):237-242
78. Toombs JA, Petri M, Paul KR, Kan GY, Ben-Hur A, Ross ED (2012) De novo design of synthetic prion domains. Proc Natl Acad Sci USA 109(17):6519-6524
79. Esteras-Chopo A, Serrano L, de la Paz ML (2005) The amyloid stretch hypothesis: recruiting proteins toward the dark side. Proc Natl Acad Sci USA 102(46):16672-16677
80. Toombs JA, McCarty BR, Ross ED (2010) Compositional determinants of prion formation in yeast. Mol Cell Biol 30(1):319-332
81. Thompson MJ, Sievers SA, Karanicolas J, Ivanova MI, Baker D, Eisenberg D (2006) The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci USA 103(11):4074-4078. doi: 10.1073/pnas.0511295103
82. Teng PK, Eisenberg D (2009) Short protein segments can drive a non-fibrillizing protein into the amyloid state. Protein Eng Des Sel 22(8):531-536. doi: 10.1093/protein/gzp037
83. Tartaglia GG, Pechmann S, Dobson CM, Vendruscolo M (2007) Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci 32(5):204-206. doi: 10.1016/j.tibs.2007.03.005
84. Prilusky J, Felder CE, Zeev-Ben-Mordehai T, Rydberg EH, Man O, Beckmann JS, Silman I, Sussman JL (2005) FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics 21(16):3435-3438
85. Espinosa Angarica V, Ventura S, Sancho J (2013) Discovering putative prion sequences in complete proteomes using probabilistic representations of Q/N-rich domains. BMC Genom 14:316. doi: 10.1186/1471-2164-14-316
86. Li SC, Goto NK, Williams KA, Deber CM (1996) Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment. Proc Natl Acad Sci USA 93(13):6676-6681
87. Halfmann R, Alberti S, Krishnan R, Lyle N, O'Donnell CW, King OD, Berger B, Pappu RV, Lindquist S (2011) Opposing effects of glutamine and asparagine govern prion formation by intrinsically disordered proteins. Mol Cell 43(1):72-84
88. Costanzo M, Zurzolo C (2013) The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration. Biochem J 452(1):1-17. doi: 10.1042/BJ20121898
89. Cushman M, Johnson BS, King OD, Gitler AD, Shorter J (2010) Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 123(Pt 8):1191-1201
90. Hall GF, Patuto BA (2012) Is tau ready for admission to the prion club? Prion 6(3):223-233. doi: 10.4161/pri.19912
91. Aguzzi A, Rajendran L (2009) The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 64(6):783-790. doi: 10.1016/j.neuron. 2009.12.016
92. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, Jucker M, Goedert M, Tolnay M (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11(7):909-913. doi: 10.1038/ncb1901
93. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130-133. doi: 10.1126/science.1134108
94. Lagier-Tourenne C, Polymenidou M, Cleveland DW (2010) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19(R1):R46-R64. doi: 10.1093/hmg/ddq137
95. Ash PE, Zhang YJ, Roberts CM, Saldi T, Hutter H, Buratti E, Petrucelli L, Link CD (2010) Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum Mol Genet 19(16):3206-3218. doi: 10.1093/hmg/ddq230
96. Johnson BS, McCaffery JM, Lindquist S, Gitler AD (2008) A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc Natl Acad Sci USA 105(17):6439-6444. doi: 10.1073/pnas.0802082105
97. Li Y, Ray P, Rao EJ, Shi C, Guo W, Chen X, Woodruff EA III, Fushimi K, Wu JY (2010) A Drosophila model for TDP-43 proteinopathy. Proc Natl Acad Sci USA 107(7):3169-3174. doi: 10.1073/pnas.0913602107
98. Da Cruz S, Cleveland DW (2011) Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol 21(6):904-919. doi: 10.1016/j.conb.2011.05.029
99. Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD (2009) TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem 284(30):20329-20339. doi: 10.1074/jbc.M109.010264
100. Sun Z, Diaz Z, Fang X, Hart MP, Chesi A, Shorter J, Gitler AD (2011) Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol 9(4):e1000614. doi: 10.1371/journal. pbio.1000614
101. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hosler BA, Cortelli P, de Jong PJ, Yoshinaga Y, Haines JL, Pericak-Vance MA, Yan J, Ticozzi N, Siddique T, McKenna-Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH Jr (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323(5918):1205-1208. doi: 10.1126/science.1166066
102. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Ganesalingam J, Williams KL, Tripathi V, Al-Saraj S, Al-Chalabi A, Leigh PN, Blair IP, Nicholson G, de Belleroche J, Gallo JM, Miller CC, Shaw CE (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323(5918):1208-1211. doi: 10.1126/science.1165942
103. Daigle JG, Lanson NA Jr, Smith RB, Casci I, Maltare A, Monaghan J, Nichols CD, Kryndushkin D, Shewmaker F, Pandey UB (2013) RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. Hum Mol Genet 22(6):1193-1205. doi: 10.1093/hmg/dds526
104. Couthouis J, Hart MP, Erion R, King OD, Diaz Z, Nakaya T, Ibrahim F, Kim HJ, Mojsilovic-Petrovic J, Panossian S, Kim CE, Frackelton EC, Solski JA, Williams KL, Clay-Falcone D, Elman L, McCluskey L, Greene R, Hakonarson H, Kalb RG, Lee VM, Trojanowski JQ, Nicholson GA, Blair IP, Bonini NM, Van Deerlin VM, Mourelatos Z, Shorter J, Gitler AD (2012) Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet 21(13):2899-2911. doi: 10.1093/hmg/dds116
105. Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A, Kanagaraj AP, Carter R, Boylan KB, Wojtas AM, Rademakers R, Pinkus JL, Greenberg SA, Trojanowski JQ, Traynor BJ, Smith BN, Topp S, Gkazi AS, Miller J, Shaw CE, Kottlors M, Kirschner J, Pestronk A, Li YR, Ford AF, Gitler AD, Benatar M, King OD, Kimonis VE, Ross ED, Weihl CC, Shorter J, Taylor JP (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495(7442):467-473. doi: 10.1038/nature11922
106. Klar J, Sobol M, Melberg A, Mabert K, Ameur A, Johansson AC, Feuk L, Entesarian M, Orlen H, Casar-Borota O, Dahl N (2013) Welander distal myopathy caused by an ancient founder mutation in TIA1 associated with perturbed splicing. Hum Mutat 34(4):572-577. doi: 10.1002/humu.22282
107. Li YR, King OD, Shorter J, Gitler AD (2013) Stress granules as crucibles of ALS pathogenesis. J Cell Biol 201(3):361-372. doi: 10.1083/jcb.201302044
108. Wolozin B (2012) Regulated protein aggregation: stress granules and neurodegeneration. Mol Neurodegener 7:56. doi: 10.1186/1750-1326-7-56
109. Gilks N, Kedersha N, Ayodele M, Shen L, Stoecklin G, Dember LM, Anderson P (2004) Stress granule assembly is mediated by prion-like aggregation of TIA-1. Mol Biol Cell 15(12):5383-5398. doi: 10.1091/mbc.E04-08-0715
110. Ramaswami M, Taylor JP, Parker R (2013) Altered ribostasis: RNA-protein granules in degenerative disorders. Cell 154(4):727-736. doi: 10.1016/j.cell.2013.07.038
111. Yamanaka K, Sasagawa Y, Ogura T (2012) Recent advances in p97/VCP/Cdc48 cellular functions. Biochim Biophys Acta 1823(1):130-137. doi: 10.1016/j.bbamcr.2011.07.001
112. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36(4):377-381. doi: 10.1038/ng1332
113. Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, Gibbs JR, Brunetti M, Gronka S, Wuu J, Ding J, McCluskey L, Martinez-Lage M, Falcone D, Hernandez DG, Arepalli S, Chong S, Schymick JC, Rothstein J, Landi F, Wang YD, Calvo A, Mora G, Sabatelli M, Monsurro MR, Battistini S, Salvi F, Spataro R, Sola P, Borghero G, Galassi G, Scholz SW, Taylor JP, Restagno G, Chio A, Traynor BJ (2010) Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68(5):857-864. doi: 10.1016/j.neuron.2010.11.036
114. Buchan JR, Kolaitis RM, Taylor JP, Parker R (2013) Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 153(7):1461-1474. doi: 10.1016/j.cell.2013.05.037
115. Alexandrov AI, Polyanskaya AB, Serpionov GV, Ter-Avanesyan MD, Kushnirov VV (2012) The effects of amino acid composition of glutamine-rich domains on amyloid formation and fragmentation. PLoS ONE 7(10):e46458. doi: 10.1371/journal.pone.0046458
116. Shorter J (2011) The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system. PLoS ONE 6(10):e26319. doi: 10.1371/journal.pone.0026319
117. Maddelein ML, Wickner RB (1999) Two prion-inducing regions of Ure2p are nonoverlapping. Mol Cell Biol 19(6):4516-4524